investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
Michael Gottesman
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
To study the function of new agents that kill MDR1-expressing cells
Related projects
Zheng-Gang Liu
TNF Signaling, Cell Death and Cancer
Brain, nervous system
Michael M. Cox
Mechanisms and applications of recombinational DNA repair
Melanoma of skin
Bin Tian
Illumina NextSeq500 DNA Sequencing System
Melanoma of skin
Ernst Lengyel
Regulation of Adhesion and Proteolysis in Ovarian Cancer
Ovary
Pathology
Walter J Atwood
Center for Cancer Signaling Networks
Melanoma of skin
Soheil Meshinchi
Biology and Prognostic Implications of FLT3 Mutations in AML
Leukaemia
Suyun Huang
Signal Integration of Transcriptional Pathways in Gliomagenesis
Brain, nervous system
Pathology
Jakub Godlewski
MicroRNA128 Regulation of Polycomb Repressor Complexes1 and 2 in Glioblastoma
Brain, nervous system
Yves Pommier
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
Leukaemia